Is neoadjuvant therapy the answer to adenocarcinoma of the esophagus?

被引:9
|
作者
Burak, WE
机构
[1] Ohio State Univ, Div Surg Oncol, Dept Surg, Arthur G James Canc Hosp, Columbus, OH 43210 USA
[2] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA
来源
AMERICAN JOURNAL OF SURGERY | 2003年 / 186卷 / 03期
关键词
adenocarcinoma; esophagus; neoadjuvant therapy;
D O I
10.1016/S0002-9610(03)00222-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
The conflicting results of randomized studies have led to confusion over the proper management of patients with esophageal adenocarcinoma. Although there is no firm evidence that neoadjuvant chemoradiation improves survival, because of the shortcomings of these trials, this method of treatment is practiced at many centers. Without the results of another multiinstitutional randomized trial, the true answer may never be known. (C) 2003 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 50 条
  • [21] Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype
    Donlon, Noel E.
    Elliott, Jessie A.
    Donohoe, Claire L.
    Murphy, Conor F.
    Nugent, Tim
    Moran, Brendan
    King, Sinead
    Ravi, Narayanasamy
    Reynolds, John, V
    ANNALS OF SURGERY, 2020, 272 (05) : 814 - 819
  • [22] Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
    Barthel, James S.
    Kucera, Stephen T.
    Lin, James L.
    Hoffe, Sarah E.
    Strosberg, Jonathan R.
    Ahmed, Irfan
    Dilling, Thomas J.
    Stevens, Craig W.
    GASTROINTESTINAL ENDOSCOPY, 2010, 71 (02) : 235 - 240
  • [23] Neoadjuvant chemoradiotherapy plus surgery compared with definitive chemoradiotherapy in adenocarcinoma of the esophagus
    Jayasekera, C. S.
    Byram, D.
    Gauden, S.
    Mitchell, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A183 - A183
  • [24] Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction
    Wilke, H
    Fink, U
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (07): : 509 - 510
  • [25] Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Shannon, Alexander H.
    Cloyd, Jordan M.
    MINERVA SURGERY, 2024, : 315 - 325
  • [26] Novel directions in neoadjuvant therapy for pancreas adenocarcinoma
    Yang, Andrew
    O'Reilly, Eileen M.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (05) : 585 - 601
  • [27] Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies
    Dave, Apeksha
    Wiseman, Jason T.
    Cloyd, Jordan M.
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (11): : 463 - 472
  • [28] Adjuvant and Neoadjuvant Systemic Therapy for Pancreas Adenocarcinoma
    Li, Daneng
    O'Reilly, Eileen M.
    SEMINARS IN ONCOLOGY, 2015, 42 (01) : 134 - 143
  • [29] Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma
    Jain, Anish J.
    Maxwell, Jessica E.
    Katz, Matthew H. G.
    Snyder, Rebecca A.
    CANCERS, 2023, 15 (16)
  • [30] Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma
    Jiang, William
    de Jong, Jelske M.
    van Hillegersberg, Richard
    Read, Matthew
    CANCERS, 2022, 14 (04)